Aptilon Announces the Extension of the Repayment Period of the DMD Loan

MONTREAL, May 24, 2011 /CNW/ -- 
MONTREAL, May 24, 2011 /CNW/ - Aptilon Corporation ("Aptilon" or the
 "Company") (TSX-V: APZ), a leader in online access to, engagement and
 interaction with physicians and healthcare professionals on behalf of
 pharmaceutical and life sciences companies, today announced that its
 indirect wholly-owned subsidiaries, DMD Marketing LP and DMD Marketing
 Corp., have come to an agreement to extend the repayment period of the
 secured promissory note in the amount of US$27,200,000 issued in
 September 2009 in connection with the purchase of substantially all the
 assets of Direct Medical Data, LLC. and BLM Incorporated related to
 their healthcare marketing services. The original note provided for
 monthly installments, and a lump sum payment of approximately
 US$12,417,000 on September 15, 2012.


The original note is replaced by a new secured promissory note in the
 amount of US$21,750,000, being the balance due under the original note
 as of April 14, 2011. The new note bears interest at the rate of 6.9%
 per annum and is repayable in increasing monthly installments (ranging
 from US$226,000 for the first 9 months to US$600,000 for 11 of the last
 12 months) from April 15, 2011 until December 15, 2015. It is secured
 and guaranteed in the same manner as the original note.


About Aptilon Corporation 


Aptilon enables pharmaceutical, biotech and medical device companies to
 effectively reach, message, connect and interact with US physicians and
 healthcare professionals on the Internet and over mobile devices via
 multiple access channels. Its innovative service offerings provide
 targeted impressions and interactions through: video and mobile
 detailing, ReachNet℠ Physician Access Channel, the DMD database and
 permission-based email services. Top US pharmaceutical companies and
 respected healthcare organizations have adopted Aptilon's solutions to
 market to, engage and interact with leading healthcare practitioners.
 For more information, visit www.aptilon.com.


ReachNet(SM) is a service mark of Aptilon Corporation.


Neither TSX Venture Exchange nor its Regulation Services Provider (as
 that term is defined in the policies of the TSX Venture Exchange)
 accepts responsibility for the adequacy or accuracy of this release.


To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/May2011/24/c6916.html



p Mr. Denis Martineaubr/ Presidentbr/ Aptilon Corporationbr/ 1-888-544-8866br/ a href="mailto:[e-mail]"[e-mail]/a /p 

Copyright